What's happening
This bill expands New York's drug take back program to include single-use and reusable electronic cigarettes.
Why it matters
Addresses Environmental Concerns. By including electronic cigarettes in the drug take back program, the bill aims to reduce the environmental impact of improperly discarded e-cigarette devices, which often contain batteries, plastics, and hazardous chemicals.
Expands Producer Responsibility. Manufacturers of single-use and reusable e-cigarettes would now be responsible for providing or funding safe disposal options, potentially encouraging better product stewardship and safer end-of-life management.
Promotes Public Health and Safety. Proper disposal of e-cigarettes can help limit youth and unauthorized access to discarded vaping products, reducing risks of misuse, accidental poisoning, or injury from leftover nicotine and device components.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Electronic cigarette manufacturers
The bill would bring single-use and reusable electronic cigarettes within the Drug Take Back Act’s definition of covered drugs.
Electronic cigarette users
The bill would extend the Drug Take Back Act’s coverage to both disposable and reusable devices they use.
Agencies implementing the Drug Take Back Act
The bill would authorize necessary rule changes before the expanded coverage takes effect 180 days after becoming law.
Headline styles
Include E-Cigs in Takeback
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Add E-Cigs to Drug Takeback
In Senate Committee · Health · Sponsor Pete Harckham
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6393
2023-2024 Regular Sessions
IN ASSEMBLY
April 6, 2023
Introduced by M. of A. PAULIN -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to expanding the drug take back act to include single-use and reusable electronic cigarettes
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 290 of the public health law, as added by chapter 120 of the laws of 2018, is amended to read as follows:
2. "Covered drug" means any substance recognized as a drug under 21 USC § 321(g)(1), as amended, and any regulations promulgated thereunder that is sold, offered for sale or dispensed in the state, whether directly or through a wholesaler, in any form including prescription and nonprescription drugs, drugs in medical devices and combination products, brand and generic drugs and drugs for veterinary use; provided however, covered drug shall additionally include single-use and reusable electronic cigarettes as defined in section thirteen hundred ninetynine-aa of this chapter; provided however covered drug shall not include: (a) vitamins or supplements; (b) herbal-based remedies and homeopathic drugs, products or remedies; (c) cosmetics, soap (with or without germicidal agents), laundry detergent, bleach, household cleaning products, shampoos, sunscreens, toothpaste, lip balm, antiperspirants or other personal care products that are regulated as both cosmetics and nonprescription drugs under the Federal Food, Drug, and Cosmetic Act; (d) pet pesticide products contained in pet collars, powders, shampoos, topical applications, or other forms; (e) drugs that are biological products as defined in subdivision twenty-seven of section sixtyeight hundred two of the education law if the manufacturer already provides a take back program; (f) drugs for which a manufacturer provides a take back program as part of a Federal Food and Drug Administration managed risk evaluation and mitigation strategy; (g) emptied injector products or emptied medical devices and their component parts
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09080-01-3
or accessories; and (h) drugs that are used solely in a clinical setting.
§ 2. This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.